No significant weaknesses identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| BRK-BBerkshire Hathaway Inc. | 676.28B | 492.62 | 11.94 | -15.46% | 17.82% | 9.6% | 1.72% | 0.22 |
| BRK-ABerkshire Hathaway Inc. | 386.34B | 738691.00 | 11.93 | 1.24% | 17.95% | 9.63% | 3.01% | 0.20 |
| AIGAmerican International Group, Inc. | 39.94B | 74.03 | -34.12 | -2.46% | 11.9% | 7.93% | 8.19% | 0.21 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 58.92B | 52.75B | 49.93B | 47.48B | 49.79B | 43.84B | 51.98B | 29.98B | 27.96B | 27.27B |
| Revenue Growth % | -0.09% | -0.1% | -0.05% | -0.05% | 0.05% | -0.12% | 0.19% | -0.42% | -0.07% | -0.02% |
| Medical Costs & Claims | 0 | 0 | 0 | 0 | 0 | 0 | 31.88B | 22.71B | 23.59B | 17.99B |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 58.92B | 52.75B | 49.93B | 47.48B | 49.79B | 43.84B | 20.11B | 7.26B | 4.37B | 9.28B |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | -0.09% | -0.1% | -0.05% | -0.05% | 0.05% | -0.12% | -0.54% | -0.64% | -0.4% | 1.12% |
| Operating Expenses | 55.64B | 52.83B | 48.46B | 47.22B | 44.51B | 51.13B | 6.76B | 3.49B | 1.51B | 5.41B |
| OpEx / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 4.63B | 4.09B | 3.87B | 5.36B | 5.01B | 4.12B | 4.54B | 3.86B | 3.84B | 3.6B |
| Combined Ratio % | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 3.28B | -74M | 1.47B | 257M | 5.29B | -7.29B | 13.35B | 3.77B | 2.86B | 3.87B |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -0.69% | -1.02% | 20.81% | -0.82% | 19.57% | -2.38% | 2.83% | -0.72% | -0.24% | 0.35% |
| EBITDA | 7.91B | 4.02B | 5.34B | 5.62B | 10.29B | -3.17B | 17.89B | 7.63B | 6.7B | 7.46B |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | 1.28B | 1.26B | 1.17B | 1.31B | 1.42B | 1.46B | 1.3B | 603M | 516M | 462M |
| Non-Operating Income | 0 | 0 | 0 | 0 | 0 | 0 | -1.3B | -608M | -520M | -466M |
| Pretax Income | 3.28B | -74M | 1.47B | 257M | 5.29B | -7.29B | 13.35B | 3.77B | 2.87B | 3.87B |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 1.06B | 185M | 7.53B | 154M | 1.17B | -1.46B | 2.44B | 882M | 126M | 1.17B |
| Effective Tax Rate % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 2.2B | -849M | -6.08B | -6M | 3.35B | -5.94B | 10.37B | 10.23B | 3.64B | -1.4B |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -0.71% | -1.39% | -6.17% | 1% | 559% | -2.78% | 2.74% | -0.01% | -0.64% | -1.39% |
| EPS (Diluted) | 1.65 | -0.78 | -6.54 | -0.01 | 3.74 | -6.84 | 11.95 | 12.94 | 4.98 | -2.17 |
| EPS Growth % | -0.68% | -1.47% | -7.38% | 1% | - | -2.83% | 2.75% | 0.08% | -0.62% | -1.44% |
| EPS (Basic) | 1.69 | -0.78 | -6.54 | -0.01 | 3.79 | -6.84 | 12.10 | 13.10 | 5.02 | 2.35 |
| Diluted Shares Outstanding | 1.33B | 1.09B | 930.56M | 910.14M | 889.51M | 869.31M | 864.88M | 787.94M | 725.23M | 657.3M |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 496.84B | 498.26B | 498.3B | 491.98B | 525.06B | 586.48B | 596.11B | 522.23B | 539.31B | 161.32B |
| Asset Growth % | -0.04% | 0% | 0% | -0.01% | 0.07% | 0.12% | 0.02% | -0.12% | 0.03% | -0.7% |
| Total Investment Assets | 338.35B | 328.18B | 513.83B | 314.21B | 337.62B | 360.67B | 588.13B | 309.15B | 90.24B | 93.61B |
| Long-Term Investments | 79.98B | 74.34B | 264.45B | 75.14B | 73.3B | 296.05B | 297.58B | 243.59B | 79.44B | 79.92B |
| Short-Term Investments | 258.38B | 253.84B | 249.38B | 239.06B | 264.32B | 289.7B | 290.56B | 238.53B | 78.11B | 36.1B |
| Total Current Assets | 41.33B | 47.41B | 261.99B | 252.95B | 277.45B | 0 | 305.17B | 0 | 0 | 0 |
| Cash & Equivalents | 1.63B | 1.87B | 2.36B | 2.87B | 2.86B | 2.83B | 2.2B | 2.04B | 1.54B | 1.3B |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | -303.86B | 0 | -253.82B | -89.61B | -47.87B |
| Goodwill & Intangibles | 1.61B | 1.53B | 1.59B | 4.08B | 4.04B | 4.07B | 4.06B | 3.93B | 3.75B | 3.37B |
| Goodwill | 1.61B | 1.53B | 1.59B | 4.08B | 4.04B | 4.07B | 4.06B | 3.93B | 3.75B | 3.37B |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PP&E (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | -81.59B | -75.86B | 182.49B | 161.37B | 157.13B | -300.12B | -11.71B | -247.52B | -83.19B | -83.29B |
| Total Liabilities | 406.63B | 421.41B | 432.59B | 434.68B | 457.64B | 519.28B | 527.2B | 478.77B | 488B | 118.77B |
| Total Debt | 29.25B | 30.91B | 31.64B | 34.54B | 35.35B | 37.53B | 30.16B | 27.18B | 10.86B | 8.92B |
| Net Debt | 27.62B | 29.04B | 29.28B | 31.67B | 32.49B | 34.71B | 27.96B | 25.14B | 9.32B | 7.62B |
| Long-Term Debt | 29.25B | 30.91B | 31.64B | 34.54B | 35.35B | 37.53B | 30.16B | 25.68B | 10.61B | 8.92B |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.5B | 250M | 0 |
| Total Current Liabilities | 0 | 0 | 14.03B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.22B | 6.05B |
| Deferred Revenue | 0 | 0 | 14.03B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | -43.06B | -40.77B | -31.88B | -11.69B | -11.21B |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 1000K |
| Other Liabilities | 377.38B | 390.49B | 400.95B | 400.13B | 422.29B | -37.53B | 497.04B | -25.68B | -10.95B | -9.35B |
| Total Equity | 90.21B | 76.86B | 65.71B | 57.31B | 67.43B | 67.2B | 68.91B | 43.45B | 51.3B | 42.55B |
| Equity Growth % | -0.16% | -0.15% | -0.15% | -0.13% | 0.18% | -0% | 0.03% | -0.37% | 0.18% | -0.17% |
| Shareholders Equity | 89.66B | 76.3B | 65.17B | 56.36B | 65.67B | 66.36B | 65.96B | 40.97B | 45.35B | 42.52B |
| Minority Interest | 552M | 558M | 537M | 948M | 1.75B | 837M | 2.96B | 2.48B | 5.95B | 29M |
| Retained Earnings | 30.94B | 28.71B | 21.46B | 20.88B | 23.08B | 15.5B | 23.79B | 34.89B | 37.52B | 35.08B |
| Common Stock | 4.77B | 4.77B | 4.77B | 4.77B | 4.77B | 4.77B | 4.77B | 4.77B | 4.77B | 4.77B |
| Accumulated OCI | 2.54B | 3.23B | 5.46B | -1.41B | 4.98B | 13.51B | 6.69B | -22.62B | -14.04B | -7.1B |
| Return on Equity (ROE) | 0.02% | -0.01% | -0.09% | -0% | 0.05% | -0.09% | 0.15% | 0.18% | 0.08% | -0.03% |
| Return on Assets (ROA) | 0% | -0% | -0.01% | -0% | 0.01% | -0.01% | 0.02% | 0.02% | 0.01% | -0% |
| Equity / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / Equity | 0.32x | 0.40x | 0.48x | 0.60x | 0.52x | 0.56x | 0.44x | 0.63x | 0.21x | 0.21x |
| Book Value per Share | 67.60 | 70.44 | 70.61 | 62.97 | 75.80 | 77.30 | 79.68 | 55.15 | 70.74 | 64.73 |
| Tangible BV per Share | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 2.88B | 3.5B | -7.82B | -394M | -1.81B | 1.04B | 6.22B | 4.13B | 6.24B | 3.27B |
| Operating CF Growth % | -0.43% | 0.22% | -3.23% | 0.95% | -3.59% | 1.57% | 5% | -0.34% | 0.51% | -0.48% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 2.22B | -259M | -6.08B | 103M | 4.12B | -5.83B | 10.91B | 11.27B | 3.88B | 2.7B |
| Depreciation & Amortization | 4.63B | 4.09B | 3.87B | 5.36B | 5.01B | 4.12B | 4.54B | 4.41B | 4.21B | 3.6B |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 153M | 1.13B | 650M | 669M | -1.5B | 6.97B | -7B | 819M | 1.7B | -667M |
| Working Capital Changes | -4.13B | -1.46B | -6.26B | -6.53B | -9.43B | -4.22B | -2.22B | -12.37B | -3.55B | -2.36B |
| Cash from Investing | 8.46B | 3.25B | 14.04B | -223M | -5.47B | -6.2B | -3.28B | -3.63B | -7.02B | 1.67B |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 2.81B | 792M | -5.71B | 2M | 2.17B | 4.68B | 0 | 3.31B | 0 |
| Purchase of Investments | -55.13B | -62.42B | -53.88B | -48.27B | -63.03B | -67.35B | -79.41B | -44.95B | -30.21B | -25.35B |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Investing | -5.09B | -5.6B | -5.77B | -5.81B | -2.19B | 1.82B | -1.74B | -5.37B | -24.69B | -3.11B |
| Cash from Financing | -11.43B | -6.83B | -5.7B | 1.25B | 7.26B | 5.06B | -3.68B | -602M | 782M | -5.06B |
| Dividends Paid | -1.03B | -1.37B | -1.17B | -1.14B | -1.14B | -1.13B | -1.11B | -1.01B | -1.03B | -1.02B |
| Share Repurchases | -10.69B | -11.46B | -6.28B | -1.74B | 0 | -500M | -2.59B | -5.2B | -2.96B | -7.14B |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | -1000K | 1000K | -1000K | 1000K | 1000K | 1000K | -1000K | -1000K | -1000K | -1000K |
| Other Financing | 3.23B | 4.13B | 2.09B | 3.06B | 7.23B | 5.07B | 4.22B | 6.41B | 6.72B | 4.49B |
| Net Change in Cash | -129M | -131M | 630M | 621M | -71M | -57M | -803M | -211M | -643M | -201M |
| Exchange Rate Effect | -1000K | 1000K | -1000K | -1000K | -1000K | 1000K | -1000K | -1000K | -1000K | -1000K |
| Cash at Beginning | 1.76B | 2.24B | 2.11B | 2.74B | 3.36B | 3.29B | 3.23B | 2.43B | 2.22B | 1.57B |
| Cash at End | 1.63B | 2.11B | 2.74B | 3.36B | 3.29B | 3.23B | 2.43B | 2.22B | 1.57B | 1.37B |
| Free Cash Flow | 2.88B | 3.5B | -7.82B | -394M | -1.81B | 1.04B | 6.22B | 4.13B | 6.24B | 3.27B |
| FCF Growth % | -0.43% | 0.22% | -3.23% | 0.95% | -3.59% | 1.57% | 5% | -0.34% | 0.51% | -0.48% |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF per Share | 2.16 | 3.21 | -8.4 | -0.43 | -2.03 | 1.19 | 7.2 | 5.25 | 8.61 | 4.98 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 94.43% | 100.14% | 97.06% | 99.46% | 89.38% | 116.64% | 74.33% | 87.43% | 89.76% | 85.82% |
| Medical Cost Ratio | 0% | 0% | 0% | 0% | 0% | 0% | 61.32% | 75.78% | 84.37% | 65.98% |
| Return on Equity (ROE) | 2.22% | -1.02% | -8.54% | -0.01% | 5.37% | -8.83% | 15.23% | 18.2% | 7.69% | -2.99% |
| Return on Assets (ROA) | 0.43% | -0.17% | -1.22% | -0% | 0.66% | -1.07% | 1.75% | 1.83% | 0.69% | -0.4% |
| Equity / Assets | 18.16% | 15.43% | 13.19% | 11.65% | 12.84% | 11.46% | 11.56% | 8.32% | 9.51% | 26.38% |
| Book Value / Share | 67.6 | 70.44 | 70.61 | 62.97 | 75.8 | 77.3 | 79.68 | 55.15 | 70.74 | 64.73 |
| Debt / Equity | 0.32x | 0.40x | 0.48x | 0.60x | 0.52x | 0.56x | 0.44x | 0.63x | 0.21x | 0.21x |
| Revenue Growth | -8.8% | -10.47% | -5.35% | -4.9% | 4.87% | -11.96% | 18.58% | -42.34% | -6.73% | -2.46% |
| 2013 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| General Insurance | - | - | - | - | 29.88B | 26.59B | 28.36B | 27.72B | 28.54B | 27.71B |
| General Insurance Growth | - | - | - | - | - | -11.03% | 6.67% | -2.25% | 2.94% | -2.89% |
| Corporate Nonsegment and Reconciling Items | - | - | - | - | 3.06B | 1.39B | 347M | 392M | 479M | 870M |
| Corporate Nonsegment and Reconciling Items Growth | - | - | - | - | - | -54.74% | -74.95% | 12.97% | 22.19% | 81.63% |
| Total Reconciling Items | - | - | - | - | 836M | -995M | 3.75B | 10.67B | -1.08B | -548M |
| Total Reconciling Items Growth | - | - | - | - | - | -219.02% | 477.39% | 184.13% | -110.10% | 49.17% |
| Life and Retirement | - | - | - | - | 16.36B | 17.27B | 19.59B | 17.65B | - | - |
| Life and Retirement Growth | - | - | - | - | - | 5.62% | 13.42% | -9.90% | - | - |
| General Insurance | - | - | 29.69B | 30.17B | - | - | - | - | - | - |
| General Insurance Growth | - | - | - | 1.61% | - | - | - | - | - | - |
| Life And Retirement | - | - | 15.59B | 14.14B | - | - | - | - | - | - |
| Life And Retirement Growth | - | - | - | -9.30% | - | - | - | - | - | - |
| Legacy portfolio | - | 5.25B | 4.39B | 3.04B | - | - | - | - | - | - |
| Legacy portfolio Growth | - | - | -16.36% | -30.79% | - | - | - | - | - | - |
| Corporate and Other | - | 4.02B | 1.41B | 636M | - | - | - | - | - | - |
| Corporate and Other Growth | - | - | -64.83% | -54.99% | - | - | - | - | - | - |
| Consumer Insurance | - | 24.05B | - | - | - | - | - | - | - | - |
| Consumer Insurance Growth | - | - | - | - | - | - | - | - | - | - |
| Commercial Insurance | - | 21.37B | - | - | - | - | - | - | - | - |
| Commercial Insurance Growth | - | - | - | - | - | - | - | - | - | - |
| AIG Property Casualty Operating | 73.66B | - | - | - | - | - | - | - | - | - |
| AIG Property Casualty Operating Growth | - | - | - | - | - | - | - | - | - | - |
| AIG Life Insurance and Retirement Operatings | 25.72B | - | - | - | - | - | - | - | - | - |
| AIG Life Insurance and Retirement Operatings Growth | - | - | - | - | - | - | - | - | - | - |
| 2013 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| International | - | - | 15.37B | 16.39B | - | - | - | 14.83B | 13.24B | 14.22B |
| International Growth | - | - | - | 6.60% | - | - | - | - | -10.75% | 7.43% |
| North America | - | - | 34.15B | 31B | - | - | - | 41.6B | 33.56B | 13.03B |
| North America Growth | - | - | - | -9.21% | - | - | - | - | -19.32% | -61.18% |
| UNITED STATES | - | 37.41B | - | - | - | - | - | - | - | - |
| UNITED STATES Growth | - | - | - | - | - | - | - | - | - | - |
| Other Foreign | - | 6.71B | - | - | - | - | - | - | - | - |
| Other Foreign Growth | - | - | - | - | - | - | - | - | - | - |
| Europe | - | 4.61B | - | - | - | - | - | - | - | - |
| Europe Growth | - | - | - | - | - | - | - | - | - | - |
| JP | - | 3.64B | - | - | - | - | - | - | - | - |
| JP Growth | - | - | - | - | - | - | - | - | - | - |
American International Group, Inc. (AIG) saw revenue decline by 2.5% over the past year.
Yes, American International Group, Inc. (AIG) is profitable, generating $3.26B in net income for fiscal year 2024 (-5.1% net margin).
Yes, American International Group, Inc. (AIG) pays a dividend with a yield of 2.06%. This makes it attractive for income-focused investors.
American International Group, Inc. (AIG) has a return on equity (ROE) of -3.0%. Negative ROE indicates the company is unprofitable.
American International Group, Inc. (AIG) has a combined ratio of 85.8%. A ratio below 100% indicates underwriting profitability.